← Evidence map

TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2021

Addition of Lenalidomide to R-CHOP Improves Outcomes in Newly Diagnosed Diffuse Large B-Cell Lymphoma in a Randomized Phase II US Intergroup Study ECOG-ACRIN E1412.

Grzegorz S Nowakowski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

64 papers cite itlatest 60 shown

2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 33555941